ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,12
-0,13%
Dow Jones
42.313,00
0,33%
Euro vs US Dollar
1,11652
-0,10%
Bitcoin
65.733,35
0,84%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:GSK
DatumZeitQuelleÜberschriftSymbolFirma
24/09/202417h07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
24/09/202412h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
19/09/202414h00GlobeNewswire Inc.Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)NYSE:GSKGSK plc
19/09/202412h26IH Market NewsAIG names new CFO; Progyny Drops 24% After Losing Key 2025 Contract; Exicure Jumps 190% With Nasdaq ExtensionNYSE:GSKGSK plc
18/09/202413h00Business WireGSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIXNYSE:GSKGSK plc
16/09/202419h04PR Newswire (US)Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles RiskNYSE:GSKGSK plc
13/09/202412h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
12/09/202416h56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
12/09/202412h34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
11/09/202412h25IH Market NewsGameStop plunges 11% on stock offering, DJT drops post-debate, GSK fails shingles vaccine trialNYSE:GSKGSK plc
06/09/202417h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
06/09/202412h14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
03/09/202412h17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
28/08/202411h50IH Market NewsHigh Volatility Expected in Nvidia Report, Ambarella Soars 20%, Hertz Strengthens Board, Apple Cuts JobsNYSE:GSKGSK plc
06/08/202422h05GlobeNewswire Inc.Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%NYSE:GSKGSK plc
01/08/202421h44Business WireUS FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefitNYSE:GSKGSK plc
31/07/202418h28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
30/07/202412h03IH Market NewsF5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback ProgramNYSE:GSKGSK plc
29/07/202412h24IH Market NewsApple Delays AI Features, Abbott Shares Plunge 7% After $495M Fine, Philips Soars 10%NYSE:GSKGSK plc
29/07/202412h23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
29/07/202412h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
19/07/202413h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
18/07/202417h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
16/07/202416h44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
15/07/202419h14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
12/07/202417h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
11/07/202414h00Business WireGSK Begins Shipping Influenza Vaccine Doses for 2024-25 SeasonNYSE:GSKGSK plc
03/07/202412h59IH Market NewsApple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More NewsNYSE:GSKGSK plc
27/06/202413h13IH Market NewsInteractive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More NewsNYSE:GSKGSK plc
08/06/202400h57Business WireUS FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
COIN
ADAUSD
Cardano
COIN
DOGEUSD
Dogecoin
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
TG
NOV
Novo Nordisk
COIN
AVAXUSD
Avalanche
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
TG
RHM
Rheinmetall
CCOM
US100
US Tech 100
NYSE
MCD
McDonalds
FX
EURGBP
Euro vs Sterling
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten